Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. InvaGen Pharmaceuticals, Inc.
FDA Inspection
•InvaGen Pharmaceuticals, Inc.•November 10, 2010

InvaGen Pharmaceuticals, Inc. – FDA Inspection, Nov 10, 2010

Record Details

This FDA Inspection record concerns InvaGen Pharmaceuticals, Inc., with an inspection on November 10, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
InvaGen Pharmaceuticals, Inc.
Inspection Date
November 10, 2010
Product Type
Drugs
Office
Center for Drug Evaluation and Research
View Company Profile

ID · 05cd8df7-f8f0-47c9-b2d0-5b2b71bcd313

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
697223
FDA center
Human Drugs
Project area
Drug Quality Assurance

FDA Citations

8
  1. 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
  2. 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
  3. 21 CFR 211.198(a)Complaint Handling Procedure
  4. 21 CFR 211.115(a)Reprocessing procedures not written or followed
  5. 21 CFR 211.160(b)(2)In-process samples representative, identified properly
  6. 21 CFR 211.165(c)Sampling and testing plans not described
  7. 21 CFR 211.22(d)Procedures not in writing, fully followed
  8. 21 CFR 211.80(a)Procedures To Be in Writing

Full citation text and observation details available on the Dashboard.

Other FDA inspections of InvaGen Pharmaceuticals, Inc.

16
DateClassificationOfficeProject area
February 9, 2026Not classifiedNew York District OfficeGeneric Drug Evaluation
October 25, 2023NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 6, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 25, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 30, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 16 other inspections on the company page
Other documents for InvaGen Pharmaceuticals, Inc.
  • FDA Inspection 1302076 - 2026-02-09
  • FDA Inspection 1223321 - 2023-10-25
  • FDA Inspection 1111971 - 2019-12-06
  • FDA Inspection 1053263 - 2018-05-25
  • FDA Inspection 1007073 - 2017-03-30

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore InvaGen Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.